Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. EFFECT Other Notice of Effectiveness
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. 8-K Event Results of operations
  7. 10-Q Report Quarterly Report
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 8-K Event Material agreement
  16. 4 Insider Changes in Ownership
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 8-K Event Executive or director change · Shareholder vote results
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 11 of 14 · 267 filings